Galleri Cancer Blood Test Moves Closer to US Approval

Published On 05 Oct, 2026
galleri-cancer-blood-test-moves-closer-to-us-approval

9 News HD: Galleri, a blood test designed to help detect multiple types of cancer, has moved closer to possible approval in the United States after a US Food and Drug Administration (FDA) advisory panel backed the test.

The Galleri test, developed by GRAIL, is designed to look for cancer-related signals in a blood sample. It is intended for adults aged 50 and above and aims to detect signals linked to more than one type of cancer.

The recent recommendation is an important step for the test, but it does not mean Galleri has received final FDA approval. The FDA is not required to follow the advice of its panel before making its final decision.

If approved, Galleri could become an important option for people looking for an additional way to check for signs of cancer. The test could also change how doctors approach early cancer detection, especially for cancers that do not currently have regular screening tests.

However, experts have also raised questions about false results and the need for further testing after a cancer signal is found. The FDA says a result showing no cancer signal does not rule out cancer, while a positive result needs follow-up testing to confirm whether cancer is present.

The FDA's final decision will be closely watched by patients, doctors and the healthcare industry. 9 News HD will continue to provide updates on Galleri, cancer testing and major health developments.